ライフサイエンスコーパス: cartilage oligomeric matrix protein

1 systemic marker of cartilage erosion, serum cartilage oligomeric matrix protein.

2 shown by a significant decrease in systemic cartilage oligomeric matrix protein.

3 of MED result from mutations in the gene for cartilage oligomeric matrix protein.

4 ncollagenous components such as aggrecan and cartilage oligomeric matrix protein.

5 Synovial fluid levels of cartilage oligomeric matrix protein, a biomarker of cart

6 derived from thrombospondin-1, a trimer, and cartilage oligomeric matrix protein, a pentamer, respect

7 members in vertebrates, TSP1 to -4 and TSP5/cartilage oligomeric matrix protein, and a single member

8 of proteolysis of type VI collagen subunits, cartilage oligomeric matrix protein, and fibronectin.

9 ha, fatty-acid-binding-protein 5, nidogen-1, cartilage oligomeric matrix protein, and insulin-like gr

10 olargin, fibromodulin, fibronectin, decorin, cartilage oligomeric matrix protein, cartilage intermedi

11 gen N-propeptidases (ADAMTS2, 3 and 14), the cartilage oligomeric matrix protein-cleaving enzymes (AD

12 Blood, Liang and colleagues demonstrate that cartilage oligomeric matrix protein (COMP) acts as a maj

13 t this, we predicted sites of deamidation in cartilage oligomeric matrix protein (COMP) and confirmed

14 xamined associations between serum levels of cartilage oligomeric matrix protein (COMP) and ethnicity

15 in expression of the TGFbeta-regulated genes cartilage oligomeric matrix protein (COMP) and thrombosp

16 Mutations in the genes encoding cartilage oligomeric matrix protein (COMP) and type IX c

17 is of the carboxymethylated subunit of human cartilage oligomeric matrix protein (COMP) by matrix-ass

18 Mutations in cartilage oligomeric matrix protein (COMP) cause two ske

19 Isolation and characterization of distinct cartilage oligomeric matrix protein (COMP) fragments der

20 Cartilage oligomeric matrix protein (COMP) functions as

21 Mutations in the human cartilage oligomeric matrix protein (COMP) gene have bee

22 the instability of a (GAC*GTC)5 tract in the cartilage oligomeric matrix protein (COMP) gene to the 4

23 Mutations in human cartilage oligomeric matrix protein (COMP) have been lin

24 Degradative fragments of cartilage oligomeric matrix protein (COMP) have been obs

25 Cartilage oligomeric matrix protein (COMP) is a cartilag

26 Cartilage oligomeric matrix protein (COMP) is a componen

27 Cartilage oligomeric matrix protein (COMP) is a member o

28 Cartilage oligomeric matrix protein (COMP) is a pentamer

29 Cartilage oligomeric matrix protein (COMP) is a secreted

30 Cartilage oligomeric matrix protein (COMP) is an importa

31 ting complex of collagen IX, matrilin-3, and cartilage oligomeric matrix protein (COMP) is essential

32 repeats and COOH-terminal globular region of cartilage oligomeric matrix protein (COMP) lead to two s

33 o seven in the exonic region of the gene for cartilage oligomeric matrix protein (COMP) leads to pseu

34 Extensive joint hypermobility, lower serum cartilage oligomeric matrix protein (COMP) levels, and e

35 ibitor of metalloproteinases 1 (TIMP-1), and cartilage oligomeric matrix protein (COMP) were assessed

36 oproteinase 3 (MMP-3), type II collagen, and cartilage oligomeric matrix protein (COMP) were examined

37 d some forms of MED result from mutations in cartilage oligomeric matrix protein (COMP), a pentameric

38 Abnormalities in cartilage oligomeric matrix protein (COMP), a pentameric

39 Degradative fragments of cartilage oligomeric matrix protein (COMP), a prominent

40 Cartilage oligomeric matrix protein (COMP), a secreted g

41 Here we show that the cartilage oligomeric matrix protein (COMP), an abundant

42 s can result from mut-ations in the gene for cartilage oligomeric matrix protein (COMP), an extracell

43 nt fluid concentrations of glucose, lactate, cartilage oligomeric matrix protein (COMP), and keratan

44 inal measurements of one such protein, serum cartilage oligomeric matrix protein (COMP), are related

45 Baseline levels of serum cartilage oligomeric matrix protein (COMP), hyaluronan (

46 ers measured included serum hyaluronan (HA), cartilage oligomeric matrix protein (COMP), keratan sulf

47 Levels of serum cartilage oligomeric matrix protein (COMP), keratan sulf

48 ed 5 OA-related biomarkers: hyaluronan (HA), cartilage oligomeric matrix protein (COMP), N-propeptide

49 Cartilage oligomeric matrix protein (COMP), or thrombosp

50 arly marker genes for chondrogenesis such as cartilage oligomeric matrix protein (COMP), type II coll

51 a1), collagen 11(alpha1), dermatopontin, and cartilage oligomeric matrix protein (COMP).

52 tal dysplasias and results from mutations in cartilage oligomeric matrix protein (COMP).

53 from mutations that cause misfolding of the cartilage oligomeric matrix protein (COMP).

54 tes extracellular matrix proteins, including cartilage oligomeric matrix protein (COMP).

55 H) patient in one of the type III repeats of cartilage oligomeric matrix protein (COMP).

56 pecific cleavage patterns of the ECM protein cartilage oligomeric matrix protein (COMP).

57 ospondin 3 (TSP3) is structurally similar to cartilage oligomeric matrix protein (COMP/TSP5), but its

58 The coiled-coil domain of cartilage oligomeric matrix protein (COMPcc) assembles i

59 n, promoting the degradation of aggrecan and cartilage oligomeric matrix protein from cartilage, fibr

60 Mutations in the cartilage oligomeric matrix protein gene (COMP) cause ps

61 ctor 2, the rat neurocan gene, and the human cartilage oligomeric matrix protein gene (COMP).

62 Cartilage oligomeric matrix protein, insulin-like growth

63 to be caused by mutations in genes encoding cartilage oligomeric matrix protein or type IX collagen.

64 e articular cartilage was controlled via the cartilage oligomeric matrix protein promoter using the T

65 Cartilage oligomeric matrix protein/thrombospondin 5 (CO

66 Cartilage oligomeric matrix protein/thrombospondin 5 (CO